Cargando…
The impact of heme biosynthesis regulation on glioma aggressiveness: Correlations with diagnostic molecular markers
BACKGROUND: The prognosis of diffusely infiltrating glioma patients is dismal but varies greatly between individuals. While characterization of gliomas primarily relied on histopathological features, molecular markers increasingly gained importance and play a key role in the recently published 5(th)...
Autores principales: | Mischkulnig, Mario, Kiesel, Barbara, Rötzer-Pejrimovsky, Thomas, Borkovec, Martin, Lang, Alexandra, Millesi, Matthias, Wadiura, Lisa I., Hervey-Jumper, Shawn, Penninger, Josef M., Berger, Mitchel S., Widhalm, Georg, Erhart, Friedrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515895/ https://www.ncbi.nlm.nih.gov/pubmed/36187350 http://dx.doi.org/10.3389/fnmol.2022.928355 |
Ejemplares similares
-
Heme Biosynthesis mRNA Expression Signature: Towards a Novel Prognostic Biomarker in Patients with Diffusely Infiltrating Gliomas
por: Mischkulnig, Mario, et al.
Publicado: (2021) -
TCGA mRNA Expression Analysis of the Heme Biosynthesis Pathway in Diffusely Infiltrating Gliomas: A Comparison of Typically 5-ALA Fluorescent and Non-Fluorescent Gliomas
por: Mischkulnig, Mario, et al.
Publicado: (2020) -
5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers
por: Hosmann, Arthur, et al.
Publicado: (2021) -
High Interobserver Agreement in the Subjective Classification of 5‐Aminolevulinic Acid Fluorescence Levels in Newly Diagnosed Glioblastomas
por: Mischkulnig, Mario, et al.
Publicado: (2020) -
Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540”
por: Hosmann, Arthur, et al.
Publicado: (2021)